Atlas Trials

Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan

Clinical trial NCT01318135 · COMPLETED

Trial details

NCT number
NCT01318135
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2009-01-01
Primary completion
2010-01-01
Enrollment
576

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.